Rhapsody Labs

Rhapsody Labs is a biotechnology company specializing in the application of generative artificial intelligence for advanced protein engineering. The company's platform utilizes proprietary machine learning algorithms to design de novo proteins with specific functional characteristics, aiming to overcome the limitations of natural protein scaffolds. By integrating deep learning models with high-throughput laboratory validation, Rhapsody Labs accelerates the design-build-test cycle for new biologics. The startup is positioned within the emerging field of programmable medicines, seeking to provide more precise and effective treatments across various therapeutic areas. The company is currently in the early stages of development, focusing on building its core technology stack and establishing proof-of-concept for its designed molecules.